Martin Friedlander, MD, PhD

The retinal implant delivers continuous neurotrophic support, potentially halting disease progression and paving the way for future treatments in neurodegenerative retinal disorders.

Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal disease

Martin Friedlander, MD, PhD, discusses phase 3 macular telangiectasia findings, highlighting the potential for a decade-long alternative to intravitreal injections.